Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "cardiomyocyte cell surface receptors" refers generically to a wide array of proteins expressed on the outer membrane of cardiac muscle (cardiomyocyte) cells. These include classic receptor types such as G protein–coupled receptors, ion channels, and enzyme-linked receptors, as well as other membrane proteins like transporters and adhesion molecules. Collectively, they mediate hormone signaling, neurotransmission, cardiac electrical activity, cellular adhesion, and response to stress or injury. Many serve as actionable therapeutic drug targets or disease biomarkers. However, this term is not a single, specific molecule or receptor, but a category encompassing hundreds of distinct proteins, each with unique biological roles and pharmacological profiles. To obtain structured information about a particular therapeutic target, a specific receptor or protein name is required (e.g., "Beta-1 adrenergic receptor" or "Cardiac sodium channel protein type 5 subunit alpha") rather than a broad class. Key details: - Cardiomyocytes express a diverse array of surface receptors, including but not limited to GPCRs, ion channels (e.g., voltage-gated sodium, calcium, potassium channels), enzyme-linked receptors (e.g., natriuretic peptide receptors such as NPR2), and adhesion molecules (e.g., VCAM1, LAMA2)[1][2][3][4][6][7]. - Drugs target many of these for the treatment of arrhythmias, heart failure, hypertension, or cardiomyopathies, but the term itself cannot be mapped to a single canonical drug-target relationship[3][4]. - Biomarkers used to identify cardiomyocytes in research include LSMEM2, SIRPA, EMILIN2, and VCAM1, but many of these are not fully specific to cardiomyocytes[3]. - Drug safety and mechanistic profiles are determined by the specific protein being targeted, not the broad class. In summary: "Cardiomyocyte cell surface receptors" is too broad to map to a single, structured target entry. Please specify a particular receptor or protein (e.g., "Beta-1 adrenergic receptor," "Cardiac sodium channel") for detailed structured information.[1][2][3][4][6][7]
Receptor agonism/antagonism; Ion channel modulation; Enzyme inhibition/activation; Signal transduction modulation; Other (depends on drug and target)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cardiomyocyte cell surface receptors.